operational guideline for hiv 2 diagnosis

Upload: pradeep36

Post on 03-Jun-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    1/14

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    2/14

    Instructions to be followed byART centers for referring clients/patients for HIV 2 diagnosis

    (RefertoFlowchart):

    I. Clients/PatientswiththefollowingreportfromtheICTCSpecimenispositiveforHIVantibodies

    (HIV

    1and

    HIV

    2;

    or

    HIV

    2alone)

    (Annexure

    8)

    will

    be

    referred

    to

    the

    nearest

    ARTcentreforregistration.

    II. TheARTcentrewillthenreferthesaidclient/patienttothedesignatedHIV2referrallaboratory asperAnnexure1

    III. ThepatientmustcarryICTCreportandareferralslip(Annexure2)dulysignedbytheARTMedicalOfficeralongwithaphotoIDtothereferrallabonanyworkingdayfromMonday

    toFridaybetween9:00AMto2:00PM.

    IV. TheHIV2referrallabwillcollectfreshbloodspecimen(serum+plasma) forHIVserostatusconfirmation

    V. SpecimenwillbetestedbyreferrallaboratoryasperthenationalalgorithmforHIV2serodiagnosis

    (Annexure

    3).

    VI. Twocopiesofreport(Annexure4)willbesenttothereferringARTcenter(bothhard&softcopy)within 4 weeks

    VII. CopyofthereporttoberetainedbythereferringARTcenter&originaltobehandedovertopatient/client

    InstructionstobefollowedatHIV2ReferralLaboratories:

    I. CheckICTCreport,ReferralslipfromARTcenter,photoIDandrelateddetailsintheformsII. Collect5mlbloodeachintwotubes oneplainandoneEDTAvacutainertubeIII. Separatetheserumfrombloodcollectedinplainvacutainer.Proceedasperthealgorithm

    forHIV2asperAnnexure3

    IV. StorethebloodcollectedinEDTAvacutainerat200C.OnlythosesampleswillbesendtoApexlaboratorywhoseresultisindeterminateeitherforHIV1,HIV2 orHIV1&2by

    Westernblot(Annexure5:PCRrequisitionform).ThesesampleswillbetestedatApex

    laboratorybyMoleculartests.

    V. ReportstobesenttoreferringARTcenterbybothassoftcopy(e mail)andahardcopy.Hardcopyofthereporttobepreparedintriplicate.Originalandacopytobesenttothe

    referringARTcentreandonecopytoberetainedintheReferrallabforrecords.

    VI. UtilizationofkitdetailstobesubmittedtoApexlaboratoryeveryquarterlyasperAnnexure6

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    3/14

    FlowchartForreferringthePatientforHIV2Testing

    Clients/Patients

    (withICTC

    Report

    Specimen

    is

    positive

    for

    HIV

    antibodies

    (HIV

    1and

    HIV

    2;

    or

    HIV

    2alone)

    andReferralslip]

    ARTCenter

    DesignatedHIV2referrallaboratory

    Collectfresh

    blood

    specimen

    TestasperthenationalalgorithmforHIV2serodiagnosis

    ReportingtoreferringARTcenter(bothhard&softcopy)

    RetainacopyofreportatARTandhandoveroriginalreporttopatient

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    4/14

    Annexure1:DesignatedHIV2referrallaboratories

    Sr.No. ReferringARTcenters Nameoflaboratory ContactName&Address

    1 Maharashtra,Mumbai,

    Dadra&NagarHaveli,

    Daman&

    Diu,

    Goa

    NARI,Pune Dr.A.R.Risbud

    ScientistF

    NationalAIDS

    Research

    Institute

    NACOlaboratory

    PlotNo.73,GBlock,MIDC,

    Bhosari,Pune411026

    Ph.No:02027331200Ext.

    Email:[email protected]

    2 Bihar,WestBengal,

    Jharkhand,Sikkim,

    SchoolofTropical

    Medicine(STM),

    Kolkata

    Dr.BhaswatiBandopadhyay

    NRLIncharge

    Dept.ofVirology,4th

    Floor,

    SchoolofTropicalmedicine,108,C.R.Avenue

    Kolkata700073.

    Ph.No:03322198538

    Email:[email protected]

    3 Delhi,Haryana,Himachal

    Pradesh,Jammu

    &Kashmir,Punjab,

    Chandigarh,Rajasthan

    NationalCentrefor

    DiseaseControl

    (NCDC), Delhi

    Dr.R.L.Icchpujani

    NRL Incharge, Centre of AIDS & Related

    Diseases, NationalCentreforDiseaseControl,

    22 ShamnathMarg,NewDelhi110054.

    Tele/Fax:011 23934517

    Email:[email protected]

    4 AndhraPradesh IIPM,Hyderabad Dr.UmaDevi

    NRL

    In

    charge

    InstituteofPreventiveMedicine,

    BSQCDepartment,Narayanguda, NearYMCA

    Hyderabad500029

    Ph.No:04027568167

    Email:[email protected]

    5 UttarPradeshand

    Uttaranchal

    NIB,Noida Dr. RebaChabra

    NRLIncharge

    NationalInstituteofBiologicals

    A32,Sec 62,NOIDA(UP)201307

    Ph.No:01202400022/2400072

    Ext.2380/2173

    Email:[email protected]

    6 Assam,Meghalaya,

    ArunachalPradesh

    Guwahati Medical

    College&Hospital

    Dr.NabaKr.Hazarika

    Dept.ofMicrobiology,

    GauhatiMedicalCollege&Hospital,

    Guwahati781032

    Ph.No:03612529457

    Email:[email protected]

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    5/14

    7 Odisha SCBMedicalCollege&

    Hospital,Cuttack

    Dr.AshokaMahapatra

    SCBMedicalCollege&Hospital,

    Cuttack,Orissa751007

    Ph.No:06712410041

    Email:[email protected]

    8 Gujarat BJMedicalCollege,

    Ahmedabad

    Dr.M.M.Vegad

    Head&Prof.Dept.ofMicrobiology,

    B.J.MedicalCollege,Asarwa,

    Ahmedabad,Gujarat380016

    Ph.No:07922683721

    Email:[email protected]

    9 Kerala,Lakshwadweep TD medical college,

    Alapuzha

    Dr.AnithaMadhavan

    SRL,DepartmentofMicrobiology.

    Govt.TDmedicalcollege,

    Alapuzha,Kerala

    688005

    Ph.No:04772282015

    Email:[email protected]

    10 Madhya Pradesh &

    Chattisgarh

    Gandhi Medical

    College,Bhopal

    Dr.DeepakDube

    SRLIncharge,DepartmentofMicrobiology,

    GandhiMedicalCollege,

    BarakktullahVishwavidyalaya,

    SultaniaRoad,Bhopal 462001.

    Ph.No:07552730502

    Email:[email protected]

    11

    Karnataka

    NIMHANS,Bangalore

    Dr.

    Anita

    Desai

    AssistantProfessor

    Dept.ofNeurovirology,NIMHANS,

    HosurRoad,Bangalore560029.

    Ph.No:08026995778Ext.

    Fax:08026564830

    Email:[email protected]

    12 Manipur,Nagaland,

    Tripura,Mizoram

    RIMS,Imphal Dr.Ng.BrajachandSingh

    NRLIncharge

    DepartmentofMicrobiology,

    RegionalInstituteofMedicalScience,P.O.

    Lamphelpat,Imphal

    (west),

    Manipur

    795004

    Ph.No:03842414750 Ext181

    Email:[email protected]

    13 TamilNadu&

    Pondicherry,Andaman&

    Nicobarislands

    MadrasMedical

    College,Chennai

    Dr. Vasanthi

    Prof&OfficeIncharge, HIVNRLLaboratory,

    TowerBlock1,RoomNo.106,

    MadrasMedicalCollege,Chennai600003

    Ph.No:04425383445Ext.

    Email:[email protected]

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    6/14

    Annexure2:ReferralSlipforHIV2testing

    TobefilledinduplicatebyARTI/C/SMO/MO.Originalcopytobesentto

    HIV2referrallaboratoryClient/patienttocarryICTCHIVreport&photoID

    Name: Surname___________Middlename ____________ Firstname___________________

    Date:_________________(DD/MM/YY) Gender: M/ F/TG Age:_________Years

    ICTCPID

    #___________

    Pre

    ART

    Reg.

    no.

    ______________

    NameandpostaladdressofreferringARTcenter:

    EmailIDofreferringARTcenter/MOincharge:

    Name&SignatureofMedicalOfficerARTcenter:

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    7/14

    Annexure 3: National HIV 2 Testing Algori thm

    TestKitstobeusedatthereferrallab:

    Rapid1:DetermineHIV1/2(FDAApproved) HIV1WesternBlot: NewLAVBlot1

    Rapid2:

    HIV

    Tridot

    HIV

    2

    Western

    Blot

    :New

    LAV

    Blot

    2

    Rapid3:ImmunocombBispotHIV1&2

    TestingAlgorithmforHIV2samples

    S.NO.

    T1 T2 T3

    ActionrequiredResults WB

    HIV1

    Result

    WBHIVDETERMINE HIVTRIDOT IMMNOCOMB

    SCREENING HIV1 HIV2 HIV1 HIV2

    1 NEG FollowupwithICTC

    throSRL

    2

    POS

    TESTBYBOTH

    HIVTRIDOT

    AND

    IMMUNOCOMB

    POS NEG POS NEG

    Nofurthertesting

    requiredasboth

    differntiatingrapid

    testsaregivingHIV1

    result

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    8/14

    3 POS POS POS POS POS

    PerformHIV1&HIV2

    WB(ToconfirmHIV

    type)

    POS NEG

    NEG POS

    POS POS

    NEG NEG

    POS IND

    IND POS

    IND IND

    4 POS NEG POS NEG POSPerformHIV2WB(To

    confirmHIV2status)

    NEG

    POS

    IND

    5 POS POS NEG NEG POS

    PerformHIV1&HIV2

    WB(ToconfirmHIV

    type)

    POS NEG

    NEG POS

    POS POS

    NEG NEG

    POS IND

    IND

    POS

    IND IND

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    9/14

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    10/14

    Annexure4:ReportFormattobeusedbyHIV2ReferralLaboratories

    Tobefilledintriplicate.TwocopiestobesendtoreferringARTcenter

    (oneforPatientandoneARTrecord)

    NameoftheReferralLaboratory

    Name:Surname___________Middlename ____________Firstname____________________

    Date:_________________(DD/MM/YY) Gender: M/ F/TG Age:_________Years

    ICTCPID# ___________ PreARTReg.no.______________

    LaboratorySampleID___________________

    NameofreferringARTcenter:

    Dateofsamplecollection(DD/MM/YY)

    Date

    of

    sample

    testing

    (DD/MM/YY)

    TestNameRapid1

    Rapid

    2

    Rapid

    3HIV1WB HIV2WB

    Nameofthekit

    Result

    FinalInterpretationofTestResult:

    SignatureoflaboratoryIncharge Date:

    POS:Positive, Neg:Negative,IND:Indeterminate,ND:NotDone,WB:WesternBlot

    ***ENDOFREPORT***

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    11/14

    Annexure5:PCRRequisitionForm

    NameoftheReferralLaboratoryrequestingPCR:

    Name: Surname___________Middlename ____________Firstname____________________

    Dateofsamplecollection:_________(DD/MM/YY)Gender: M/ F/TG Age:_________Years

    ICTCPID# ___________ PreARTReg.no.______________

    LaboratorySampleID___________________

    NameofreferringARTcenter:

    Address

    of

    referring

    ART

    center:

    Serologicaltestresultatthereferrallaboratory:

    SignatureoflaboratoryIncharge:

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    12/14

    Annexure6:Inventoryforkitutilization

    (TobesentquarterlytoApexlaboratorybyemail)

    Date:

    Nameofkit BatchNo./

    Expirydate

    No.ofkits

    received

    No.ofkits

    used

    Balance

    DetermineTM

    HIV1/2

    HIVTridot

    ImmunocombBispot

    HIV1/HIV2

    NewLav

    Blot1

    NewLavBlot2

    SignatureofLaboratoryIncharge:

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    13/14

    Annexure7: HIV2ReferralLaboratoryCumulativeMonthlyReportingFormat

    NameofHIV2ReferralLaboratory:

    HIV2ReferralLaboratorycumulativeMonthlyReportingFormat

    Month/Year

    Number

    ofART

    centers

    referring

    patients

    Number

    of

    patients

    received

    Number

    of

    primary

    samples

    collected

    Number

    thatare

    only

    HIV1

    Positive

    Number

    thatare

    only

    HIV2

    Positive

    Number

    thatare

    both

    HIV1&

    HIV2

    Positive

    Number

    thatare

    referred

    toApex

    labfor

    further

    testing

    Number

    thatare

    HIV

    Negative

    Number

    of

    samples

    thatare

    rejected

    SignatureofLaboratoryIncharge:

  • 8/12/2019 Operational Guideline for HIV 2 Diagnosis

    14/14

    Annexure8:ICTCHIVTestReportingFormat

    HIVTESTREPORTFORMNameandaddressofICTCcentre: (Formtobefilledinduplicate)

    Name:Surname___________ Middlename____________ Firstname ____________________

    Gender: M/ F/TG Age:_________Years PID# ___________ LabID#_____________

    Dateandtimeblooddrawn:____________________(DD/MM/YY) ________________________(HH:MM)

    TestDetails:

    Specimentype

    used

    for

    testing:

    Serum

    /Plasma

    /Whole

    Blood

    Dateandtimespecimentested: ___________(DD/MM/YY) ___________(HH:MM)

    Note:

    Column2and3tobefilledonlywhenHIV1&2antibodydiscriminatorytest(s)used Nocellhastobeleftblank;indicateasNAwherenotapplicable.

    Column1 Column2 Column3 Column4

    NameofHIVtestkit

    Reactive/Nonreactive(R

    /NR) for HIV1

    antibodies

    Reactive/Nonreactive

    (R/NR) for HIV2

    antibodies

    Reactive/Nonreactive

    (R/NR) forHIVantibodies

    TestI:

    TestII:

    TestIII:

    Interpretationoftheresult: Tick()relevant

    Specimenisnegative forHIVantibodies

    SpecimenispositiveforHIV1antibodies

    *SpecimenispositiveforHIVantibodies(HIV1andHIV2;orHIV2alone)

    Specimen

    is

    indeterminate

    for

    HIV

    antibodies.

    Collect

    fresh

    sample

    in

    two

    weeks.

    *ConfirmationofHIV2sero statusatidentifiedreferrallaboratorythroughARTcentres

    Name&Signature Name&Signature

    LaboratoryTechnician LaboratoryIncharge

    Endofreport